CIK: 1528382 - Address: 888 Boylston Street, Suite 1111, Boston, MA 02199
17 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
3/16/22 21:54
3/14/22
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagOmega Fund Iv, L.P.MATM.d1619.7801709,437M
3/16/22 21:54
3/14/22
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagOmega Fund Iv, L.P.MATS.dm-1,65615.550-107-19,437M
11/23/21 16:53
11/19/21
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagOmega Fund Iv, L.P.MADTS.m-1,57134.580-45-14,763D
11/18/21 18:30
11/16/21
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagOmega Fund Iv, L.P.MADTS.m-8733.500-304,809D
11/18/21 18:30
11/16/21
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagOmega Fund Iv, L.P.MADTS.m-8733.500-304,809D
11/16/21 13:29
11/12/21
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagOmega Fund Iv, L.P.MADTS.m-80833.660-2404,811D
11/12/21 13:08
11/10/21
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagOmega Fund Iv, L.P.MADTS.m-61533.610-1804,835D
11/10/21 12:16
11/8/21
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagOmega Fund Iv, L.P.MADTS.m-38233.660-1104,854D
11/8/21 14:14
11/4/21
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagOmega Fund Iv, L.P.MADTS.m-1,04133.570-31-14,865D
9/27/21 20:50
9/23/21
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagOmega Fund Iv, L.P.MADTS-40933.580-1204,896D
9/20/21 12:53
9/16/21
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagOmega Fund Iv, L.P.MADTS.m-3,29932.990-100-24,908D
2/11/21 11:50
2/8/21
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagOmega Fund Iv, L.P.MATS-23645.000-505,141D
1/28/21 09:27
1/26/21
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagOmega Fund Iv, L.P.MADTS-1,37845.420-30-15,284D
1/26/21 09:56
1/22/21
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagOmega Fund Iv, L.P.MADTS-51245.040-1105,314D
1/19/21 15:02
1/14/21
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagOmega Fund Iv, L.P.MADTS.m-88345.100-2005,325D
11/20/19 12:36
11/18/19
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagOmega Fund Iv, L.P.MATP2,99413.61022045,329D
7/25/18 17:09
7/24/18
REPLReplimune Group, Inc.MAHealthBioPrdBiological Products, (No DiagOmega Fund Iv, L.P.MATP.d4,00015.00026764,855D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact